share_log

新興市場銘柄ダイジェスト:エクストリームは大幅続伸、ノイルイミューンが急反発

Emerging markets stock digest: Extreme continues to rise significantly, while Noil Immune rebounds sharply.

Fisco Japan ·  Sep 26 02:08

Extreme 1142 +58

Significant rise. The toro announced that the cumulative worldwide sales of the zombie action game 'Lollipop Chainsaw RePOP' by its subsidiary Dragami Games (including the number of packaged units shipped plus the number of digital downloads) exceeded 0.1 million units in the first week after release, leading to buying activity. The game supports English, Japanese, traditional Chinese, French, Italian, German, Spanish, Latin American Spanish, and Brazilian Portuguese, and is scheduled for release in North, Central, and South America and Europe on September 12th, followed by Japan and the Asia region on September 26th.

Sea You Sea 1601 +69

Significant gains. It was announced after the end of trading on the 25th that all of Noa Concert's issued shares were acquired and consolidated as a subsidiary, which was well received by buyers. Noa Concert operates residential-type nursing homes and service-oriented housing for the elderly in Sapporo City, providing regular patrol and on-demand visiting nursing care services to residents. With this subsidiary, they will launch the "regular patrol and on-demand visiting nursing care services" more efficiently to a larger number of users and plan to establish a hospice floor within the facility.

Axis C 1058 +16

Sharp rise. The aeye inc announced the strengthening of its business partnership with StartPass and the launch of the service 'CxO-Pass,' a matching service where consultants can start working in CxO positions at startups as a side job. This announcement has been viewed positively as a favorable development. 'CxO-Pass' allows consultants to leverage their consulting firm experience and skills to support startup founders as their right-hand person. The company introduces job seekers to the job offers of startups who are clients of StartPass, matching them based on skills and preferences.

Air Crow 377 +12

Rebound. After the close of trading on the 25th, it was announced that they have begun entrusted business to re-commercialize damaged goods and other items for United Arrows. This entrusted business of re-commercializing damaged goods and others this time is a case of "individual customization", and United Arrows will enhance the "re-commercialization of B-grade products" that they have been working on as part of their sustainability activities "SARROWS", by introducing a circular platform for verification, they have started collaborating with the company. By reducing product disposal, they aim to promote a circular economy in the apparel industry and solve the problem of clothing waste.

Stock code 4388, aeye inc, is at 609, up 13 points.

Significant rise. They announced the signing of a partner contract with Genesys Cloud Services, the global leader in contact center solutions, and AppFoundry ISV to promote collaboration in the field of voice synthesis. Aiming for functional collaboration between Genesys Cloud CX and their voice synthesis engine AITalk solution, in the Japanese market where there is a high demand for the quality of phone response messages, they will provide high-quality and controllable AITalk to customers using Genesys Cloud CX.

Stock code 4893, noilimmune, is at 191, up 12 points.

Surged. Forge a business alliance agreement with Takara Bio to develop their in-house PRIME CAR-T cells NIB103 using cancer patients' own lymphocytes. Takara Bio will exclusively handle the production of clinical trial products and commercial products after market launch, bearing the costs related to the production of trial products. The company will exclusively handle the development tasks excluding manufacturing of NIB103 within Japan, as well as post-market sales, and bear the costs associated with them. The company will continue to exclusively own all rights related to the development, manufacturing, and sales of NIB103 overseas.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment